(Q34756451)

English

Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

author name string

Leina Sun

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Qiang Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Huanling Luan

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Zhongli Zhan

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Changli Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Baocun Sun

6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

17 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Journal of Experimental & Clinical Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

17 March 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1756-9966-30-30

0 references

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Integrating epidermal growth factor receptor-targeted therapies into platinum-based chemotherapy regimens for newly diagnosed non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

A progression puzzle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

7 July 2018

Targeted therapies in lung cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-30-30

21 January 2018

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-30-30

21 January 2018

Identification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapy

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-30-30

21 January 2018

The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-30-30

21 January 2018

Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-30-30

21 January 2018

EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-30-30

21 January 2018

KRAS mutation status in primary nonsmall cell lung cancer and matched metastases.

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-30-30

21 January 2018

Epidermal growth factor receptor expression status in lung cancer correlates with its mutation

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-30-30

21 January 2018

EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-30-30

21 January 2018

Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications.

1 reference

https://api.crossref.org/works/10.1186%2F1756-9966-30-30

21 January 2018

K-ras gene mutations in non-small cell lung cancer in Japanese

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069944

26 October 2018

Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21414214

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/21414214

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532

1 reference

https://pubmed.ncbi.nlm.nih.gov/21414214

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative genomic hybridization analysis suggests a gain of chromosome 7p associated with lymph node metastasis in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21414214

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21414214

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003

1 reference

https://pubmed.ncbi.nlm.nih.gov/21414214

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1756-9966-30-30

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34756451&oldid=1807767987"